SCIBASE RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 58 MILLION

STOCKHOLM, Sept. 3, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, pursuant to the authorisation granted by the annual general meeting held on 19 May 2026, resolved to carry out an issue of shares of approximately SEK 57.5 million, before deduction of transaction costs, with preferential rights for the Company's shareholders (the "Rights Issue"). All existing shareholders will receive one (1) subscription right for each share held on the record date of 10 September 2026. Eight (8) subscription rights entitle the holder to subscribe for three (3) new shares in the Company at a subscription price of SEK 15 per share. A number of existing shareholders, including Ribbskottet AB, Castle Biosciences Inc, Haga Gruppen Holding AB, Life Science Invest Fund 1 ApS and Praktikerinvest AB, have provided subscription undertakings amounting in aggregate to approximately SEK 33.3 million, corresponding to approximately 58 percent of the Rights Issue. In addition, Bergs Securities AB ("Bergs Securities") has entered into a letter of intent to provide a guarantee commitment of approximately SEK 24.2 million prior to the expiry of the subscription period, corresponding to approximately 42 percent of the Rights Issue (the "Guarantee Intention"). In connection with the Guarantee Intention, Bergs Securities has entered into sub-guarantee agreements with a consortium of investors corresponding to the entire intended guarantee commitment. The subscription undertakings and the Guarantee Intention amount in aggregate to approximately SEK 57.5 million, corresponding to the entire Rights Issue. The net proceeds from the Rights Issue are primarily intended to be used to drive the Company's continued commercialisation with a focus on the US market.